These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 29692458)

  • 21. Microsporum audouinii tinea capitis in a Swiss school: assessment and management of patients and asymptomatic carriers.
    Donghi D; Hauser V; Bosshard PP
    Med Mycol; 2011 Apr; 49(3):324-8. PubMed ID: 20936914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Tinea capitis: two years experience in a paediatric hospital of Buenos Aires, Argentina].
    Santos PE; Córdoba S; Rodero LL; Carrillo-Muñoz AJ; Lopardo HA
    Rev Iberoam Micol; 2010 Jun; 27(2):104-6. PubMed ID: 20346290
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro pharmacodynamic characteristics of griseofulvin against dermatophyte isolates of Trichophyton tonsurans from tinea capitis patients.
    Gupta AK; Williams JV; Zaman M; Singh J
    Med Mycol; 2009 Dec; 47(8):796-801. PubMed ID: 19212895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral griseofulvin remains the treatment of choice for tinea capitis in children.
    Bennett ML; Fleischer AB; Loveless JW; Feldman SR
    Pediatr Dermatol; 2000; 17(4):304-9. PubMed ID: 10990583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tinea capitis: a current perspective.
    Elewski BE
    J Am Acad Dermatol; 2000 Jan; 42(1 Pt 1):1-20; quiz 21-4. PubMed ID: 10607315
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic options in the treatment of tinea capitis.
    Chan YC; Friedlander SF
    Expert Opin Pharmacother; 2004 Feb; 5(2):219-27. PubMed ID: 14996619
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dermatophytosis of children in Kuwait: a prospective survey.
    al-Fouzan AS; Nanda A; Kubec K
    Int J Dermatol; 1993 Nov; 32(11):798-801. PubMed ID: 8270336
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antifungal activity of silver nanoparticles on Fluconazole resistant Dermatophytes identified by (GACA)4 and isolated from primary school children suffering from Tinea Capitis in Ismailia - Egypt.
    Amin ME; Azab MM; Hanora AM; Abdalla S
    Cell Mol Biol (Noisy-le-grand); 2017 Nov; 63(11):63-67. PubMed ID: 29208175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antifungal Activity of Neem Leaf Extract With Eucalyptus citriodora Oil and Cymbopogon martini Oil Against Tinea Capitis: An In-Vitro Evaluation.
    Tiple RH; Jamane SR; Khobragade DS
    Cureus; 2024 May; 16(5):e59671. PubMed ID: 38836134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Griseofulvin vs terbinafine for paediatric tinea capitis: When and for how long.
    Bar J; Samuelov L; Sprecher E; Mashiah J
    Mycoses; 2019 Oct; 62(10):949-953. PubMed ID: 31343780
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Griseofulvin and terbinafine in the treatment of tinea capitis in children.
    Rademaker M; Havill S
    N Z Med J; 1998 Feb; 111(1060):55-7. PubMed ID: 9539918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Once weekly fluconazole is effective in children in the treatment of tinea capitis: a prospective, multicentre study.
    Gupta AK; Dlova N; Taborda P; Morar N; Taborda V; Lynde CW; Konnikov N; Borges M; Raboobee N; Summerbell RC; Adam P; Hofstader SL; Aboobaker J
    Br J Dermatol; 2000 May; 142(5):965-8. PubMed ID: 10809856
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy, safety and tolerability of terbinafine for Tinea capitis in children: Brazilian multicentric study with daily oral tablets for 1,2 and 4 weeks.
    Filho ST; Cucé LC; Foss NT; Marques SA; Santamaria JR
    J Eur Acad Dermatol Venereol; 1998 Sep; 11(2):141-6. PubMed ID: 9784040
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Three Cases of Recalcitrant Pediatric Tinea Capitis Successfully Treated with Griseofulvin.
    Jung ES; Lee SK; Lee IJ; Nam KH; Yun SK; Kim HU; Park J
    Ann Dermatol; 2023 Nov; 35(Suppl 2):S247-S251. PubMed ID: 38061714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Guidelines for the management of tinea capitis in children.
    Kakourou T; Uksal U;
    Pediatr Dermatol; 2010; 27(3):226-8. PubMed ID: 20609140
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tinea Capitis: An Updated Review.
    Leung AKC; Hon KL; Leong KF; Barankin B; Lam JM
    Recent Pat Inflamm Allergy Drug Discov; 2020; 14(1):58-68. PubMed ID: 31906842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimizing the therapeutic approach in tinea capitis of childhood with itraconazole.
    Möhrenschlager M; Schnopp C; Fesq H; Strom K; Beham A; Mempel M; Thomsen S; Brockow K; Wessner DB; Heidelberger A; Ruhdorfer S; Weigl L; Seidl HP; Ring J; Abeck D
    Br J Dermatol; 2000 Nov; 143(5):1011-5. PubMed ID: 11069511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tinea Capitis by Microsporum audouinii: Case Reports and Review of Published Global Literature 2000-2016.
    Brito-Santos F; Figueiredo-Carvalho MHG; Coelho RA; Sales A; Almeida-Paes R
    Mycopathologia; 2017 Dec; 182(11-12):1053-1060. PubMed ID: 28736794
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro antifungal susceptibility of Trichophyton violaceum isolated from tinea capitis patients.
    Deng S; de Hoog GS; Verweij PE; Zoll J; Ilkit M; Morsali F; Abliz P; Wang X; Zhan P; Yang L; Hasimu H; Liao W; Pan W; Seyedmousavi S
    J Antimicrob Chemother; 2015 Apr; 70(4):1072-5. PubMed ID: 25492394
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized comparison of 4 weeks of terbinafine vs. 8 weeks of griseofulvin for the treatment of tinea capitis.
    Fuller LC; Smith CH; Cerio R; Marsden RA; Midgley G; Beard AL; Higgins EM; Hay RJ
    Br J Dermatol; 2001 Feb; 144(2):321-7. PubMed ID: 11251566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.